InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Alhydrogel® adjuvant 2% | An investigation and assessment of the muscle damage and inflammation at inje... | 2022 | J Toxicol Sci. | Sasaki E. et al. | DOI: 10.2131/jts.47.439 |
Primocin® | Establishment, characterization and functional testing of two novel ex vivo e... | 2022 | Hum Cell | Bangerter J.L. et al. | DOI: 10.1007/s13577-022-00818-x |
Nigericin | SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through sp... | 2022 | Mol Psychiatry | Albornoz E.A. et al. | DOI: 10.1038/s41380-022-01831-0 |
Caspase-1 and Caspase-4 inhibitor | SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through sp... | 2022 | Mol Psychiatry | Albornoz E.A. et al. | DOI: 10.1038/s41380-022-01831-0 |
LPS-EB (LPS from E. coli O111:B4) | SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through sp... | 2022 | Mol Psychiatry | Albornoz E.A. et al. | DOI: 10.1038/s41380-022-01831-0 |
NLRP3 inflammasome inhibitor - MCC950 | SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through sp... | 2022 | Mol Psychiatry | Albornoz E.A. et al. | DOI: 10.1038/s41380-022-01831-0 |
Normocin® - Antimicrobial Reagent | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR3 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR9 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR8 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Polymyxin B | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR5 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR7 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation... | 2022 | Int J Mol Sci. | Fernández-Lainez C. et al. | DOI: 10.3390/ijms231911552 |
Plasmocin® - Mycoplasma Elimination Reagent | The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by pe... | 2022 | Nat Commun. | Bauer J. et al. | DOI: 10.1038/s41467-022-33746-3 |
G418 (Geneticin) | The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by pe... | 2022 | Nat Commun. | Bauer J. et al. | DOI: 10.1038/s41467-022-33746-3 |
Recombinant human IFN-γ protein - Bioactive cytokine | A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors. | 2022 | Inflammation | Yu B. et al. | DOI: 10.1007/s10753-022-01758-2 |
Recombinant human TGF-β1 protein - Bioactive cytokine | A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors. | 2022 | Inflammation | Yu B. et al. | DOI: 10.1007/s10753-022-01758-2 |
Puromycin | Transient inhibition of p53 enhances prime editing and cytosine base-editing ... | 2022 | Nat Commun. | Li M. et al. | DOI: 10.1038/s41467-022-34045-7 |